Elevance Health, Inc. (ELV)
What changed in recent filings
- Institutions — 5 new · 1 reduced13F · as of end of 2026 Q2
What changed in recent SEC filings — factual, not a buy/sell recommendation.
Institutions holding Elevance Health, Inc.
How many of the institutions we track reported holding this stock, quarter by quarter.
2019 Q1: 8 → 2026 Q2: 8 institutions
Counts the 52 institutions we track that reported holding this stock — their full reported holdings, not just the largest positions. Not the total number of institutional holders in the US. Figures are as of quarter-end and disclosed up to 45 days later. Descriptive only — not investment advice.
Which institutions hold Elevance Health, Inc.
Institutions we track that reported holding this stock in their most recent 13F.
- Baillie Gifford & Co0.38% of portfolio · held as of 2019 Q1 or earlier
- Dodge & Coxunder 0.01% of portfolio · held as of 2019 Q1 or earlier
- Baupost Group9.11% of portfolio · since 2025 Q1
- Glenview Capital ManagementNew this quarter0.47% of portfolio · since 2026 Q2
- National Pension Service (Korea)0.15% of portfolio · held as of 2026 Q2 or earlier
- Harris Associates (Oakmark)2.53% of portfolio · held as of 2026 Q2 or earlier
- Pzena Investment Management0.25% of portfolio · held as of 2026 Q2 or earlier
- Caisse de depot (Quebec)0.13% of portfolio · held as of 2026 Q2 or earlier
Based on 13F filings — quarter-end holdings, disclosed up to 45 days later. Holding a stock is a fact we report, not a recommendation to buy or sell.
Company overview
Elevance Health (formerly Anthem). A large US health-insurance company. It holds over 40 million members via the Blue Cross Blue Shield network.
What is the Biotech & Health sector?
Pharma, biotech, and medical devices. Driven by trial-result events.
Elevance Health, Inc. is classified under the Biotech & Health sector. See peers below.
Elevance Health, Inc. key financials
Based on SEC filings · as of Jun 30, 2026
Tap a metric name to see its meaning in the glossary.
Elevance Health, Inc. vs Biotech & Health sector benchmark
Median of 35 representative sector stocks · SEC filings · factual comparison (not advice)
A simple comparison to the sector benchmark. Higher or lower doesn’t mean good/bad or buy/sell.
ETFs holding Elevance Health, Inc.
Per SEC N-PORT · 2026-06-30 · by weight · factual
ELV on Stocklore
- Revenue by segment — segment weights verified from SEC filings, YoY changes, growth drivers and concentration
- Financials & earnings quality — 6 metrics (FCF conversion, ROIC, net debt, etc.) to gauge profit quality
- 13F institutional holdings — holdings and weight changes of major institutions (45-day delay)
- Sector-relative metrics — Valuation and growth compared with the Biotech & Health average
Peers · Biotech & Health
ELV FAQ
What is Elevance Health, Inc. (ELV)?
Elevance Health (formerly Anthem). A large US health-insurance company. It holds over 40 million members via the Blue Cross Blue Shield network.
What sector is Elevance Health, Inc. in?
Elevance Health, Inc. is classified under Biotech & Health. Pharma, biotech, and medical devices. Driven by trial-result events.
What are Elevance Health, Inc.'s key financials?
As of Jun 30, 2026 in SEC filings: Revenue growth (YoY) 6.3%, Operating margin 3.5%, Net margin 2.5%, ROE 12.9%, Debt-to-equity 0.69x. Definitions and interpretation are available on Stocklore.
Where can I analyze Elevance Health, Inc. (ELV) stock?
On Stocklore you can see ELV's financials & earnings quality, 13F institutional holdings, and sector-relative metrics in one place. This page is for information and tools — not a buy/sell recommendation.
Data sources: SEC EDGAR (financials & filings), 13F (institutional holdings, as of quarter-end), market data. This page is for information and analysis tools — it does not recommend buying or selling any security. Investment decisions and responsibility are your own.